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Abstract
Francisella tularensis is a highly infectious bacterium causing the zoonotic disease tularemia. Its ability to multiply and
survive in macrophages is critical for its virulence. By screening a bank of HimarFT transposon mutants of the F. tularensis
live vaccine strain (LVS) to isolate intracellular growth-deficient mutants, we selected one mutant in a gene encoding a
putative c-glutamyl transpeptidase (GGT). This gene (FTL_0766) was hence designated ggt. The mutant strain showed
impaired intracellular multiplication and was strongly attenuated for virulence in mice. Here we present evidence that the
GGT activity of F. tularensis allows utilization of glutathione (GSH, c-glutamyl-cysteinyl-glycine) and c-glutamyl-cysteine
dipeptide as cysteine sources to ensure intracellular growth. This is the first demonstration of the essential role of a nutrient
acquisition system in the intracellular multiplication of F. tularensis. GSH is the most abundant source of cysteine in the host
cytosol. Thus, the capacity this intracellular bacterial pathogen has evolved to utilize the available GSH, as a source of
cysteine in the host cytosol, constitutes a paradigm of bacteria–host adaptation.
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Introduction
Francisella tularensis is a Gram-negative bacterium capable of
causing the disease tularemia in a large number of mammalian
species. It is a highly infectious bacterium that can be transmitted
to humans in numerous ways. Four different subspecies (subsp.) of
F. tularensis that differ in virulence and geographic distribution
exist. These are designated subsp. tularensis (type A), holarctica (type
B), novicida and mediasiatica. F. tularensis subsp. tularensis is the most
virulent subspecies causing a severe disease in humans, whereas F.
tularensis subsp. holarctica causes a similar disease but of less severity
[1]. Because if its high infectivity and lethality, F. tularensis is
considered a potential bioterrorism agent [2].
F. tularensis is a facultative intracellular bacterium that infects
and replicates mainly inside macrophages, but which can also
infect hepatocytes, endothelial cells, epithelial cells, fibroblasts,
chicken embryos, and amoebae [3]. Although the molecular
mechanisms by which Francisella adapts to life inside host cells are
not well understood, a number of genes that are necessary for
Francisella to survive inside its host and cause disease are known
[4]. These include genes located in the Francisella pathogenicity
island (FPI) [5,6,7,8,9,10,11], the genes encoding the regulatory
proteins MglA, SspA, and PmrA, which regulate expression of the
FPI [5,12,13] and the genes responsible for lipopolysaccharide
(LPS) production [14,15,16,17]. Furthermore, several genome-
scale screening approaches have been formerly utilized in F.
tularensis subsp. novicida, tularensis, and holarctica, to identify additional
genes that are important for replication inside macrophages or
survival in mice [7,18,19,20,21].
In the present work, we designed an in vitro negative selection
method, based on the use of a bacteriostatic antibiotic, to recover
intracellular growth mutants directly from a pool of mutants. A
similar approach has been reported earlier to select intracellular
growth-deficient mutants of Listeria monocytogenes [22].
One of the mutants isolated by this procedure (see Table S1)
showed a drastic intracellular growth defect. This mutant had an
insertion into gene FTL_0766, encoding a putative gamma-
glutamyl transpeptidase, GGT.
We focus here on the role of this gene in the virulence of F.
tularensis. GGT’s are involved in hydrolysis of c-glutamyl
compounds such as glutathione (GSH). GSH is a non-ribosomal
tripeptide (L-c-L-glutamyl-L-cysteinyl-glycine) present in almost
all eukaryotic cells and in some prokaryotes. In eukaryotes, GSH is
essential for cell homeostasis and GSH-deficiency has been
associated with various severe diseases [23]. In mammalian
tissues, GSH is generally found in the cytosol at mM levels (1–
10 mM) [24]; and GSH biosynthesis and metabolism proceeds
through the c-glutamyl cycle [25]. In all living organisms, GGT
catalyzes the first step in the degradation of GSH, which involves
the cleavage and transfer of the c-glutamyl moiety from GSH to
an amino acid acceptor (or hydrolysis to release glutamate) and
release of cysteinyl-glycine.
The four subspecies of F. tularensis require cysteine for growth;
and defined media, containing cysteine and other amino acids
essential to support growth of F. tularensis strains, have been
developed [26,27]. In silico analysis of the F. tularensis SCHU S4
genome suggests that the specific requirement for cysteine is due to
a nonfunctional pathway for sulfate assimilation, resulting from a
pseudogene encoding adenylylsulfate kinase [27].
We demonstrate here that FTL_0766 of F. tularensis encodes a
genuine GGT involved in the metabolism of c-glutamyl-
containing peptides. GGT allows the utilization of c-glutamyl
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of the pathogen, and is thus critical for virulence.
Results
Selection of F. tularensis mutants unable to multiply in
J774 macrophages
In the present work, we adapted an in vitro negative screening
procedure, based on a penicillin selection, for the isolation of F.
tularensis mutants defective in their ability to replicate intracellu-
larly. F. tularensis has been shown to be sensitive to a series of
antibiotics [28]. Although penicillins are generally not very active
on F. tularensis, cephalosporins are more active. In particular,
cefotaxime, a third generation cephalosporin with bacteriostatic
activity, was shown to be active on F. tularensis [28]. This antibiotic
was furthermore demonstrated to enter eukaryotic cells [29].
Therefore, since b-lactam antibiotics such as cefotaxime, kill only
growing bacteria, a protocol was designed to isolate intracellular
growth mutants from banks of transposon insertion mutants.
Banks of mutants were generated in the F. tularensis Live
Vaccine Strain (LVS), using the in vivo Himar strategy (HimarFT)
[30]. The thermosensitive plasmid pFNLTP16 H3 (which carries a
kanamycine resistance cassette between the inverted repeats) was
introduced into LVS by electroporation. Transformants were first
selected for inheritance and maintenance of the plasmid at
permissive temperature (30uC). Then, cultures were shifted at non-
permissive temperature (39uC) to inhibit subsequent plasmid
replication, and in the presence of kanamycin to select
chromosomal integration of the resistance cassette (see Materials
and Methods).
Wild-type LVS multiplies in murine macrophage-like cells J774
with an intracellular doubling time of ca. 6 h. However, the
presence of 1.5 mg ml
21 cefotaxime in the culture medium
efficiently inhibited multiplication of intracellular LVS (Figure S1).
We infected J774 cells with pools of mutant bacteria at an MOI of
100 bacteria/cell in the presence of 1.5 mg ml
21 cefotaxime. The
surviving bacteria were recovered at selected intervals after
infection by plating onto chocolate agar plates (Text S1; Figure
S1). Clones isolated by this procedure were tested by Southern blot
to select single insertion mutants (Figure S2). Nucleotide sequence
analysis of 30 single transposon insertions led to the identification
of 10 distinct chromosomal regions (Table S1, Figure S2).
The fact that the largest numbers of mutant hits (10/30) were
found in the ggt gene (FTL_0766), and that the mutation led to the
most severe intracellular growth defects (see below), prompted us
to focus on this mutant. This gene encodes a putative c-glutamyl
transpeptidase (GGT), a protein of 601 amino acid residues whose
sequence is highly conserved among the Francisella subspecies
(99.2% identity with the subsp. novicida ortholog FTN_1159; and
98.8% with the subsp. tularensis SCHU S4 ortholog FTT1181c);
and significant degree of homology with GGT of Helicobacter pylori
(47% identity).
Intracellular growth and virulence of the ggt mutant
Growth of the ggt mutant was undistinguishable from that of
wild-type LVS in broth (Mueller-Hinton, not shown or Chemical
Defined medium, see below). The kinetics of intracellular
multiplication of the ggt mutant was first followed in mouse
macrophages over a 48 h-period. The mutant showed a drastic
growth defect, with more than a 100-fold reduction of intracellular
bacteria in macrophage-like J774 cells after 24 h (Figure 1A). A
severe intracellular growth defect of the ggt mutant was also
observed in the RAW macrophagic cell line as well as in murine
bone marrow-derived macrophages (BMM) (Figure 1B and 1C).
We then followed intracellular survival of the ggt mutant in human
macrophages. The mutant showed a severe growth defect in
THP1 macrophages, with more than a 10-fold reduction of
intracellular bacteria cells after 24 h, and a down to a 20-fold
reduction after 48 h (Figure 1D).
Infection of RAW cells was followed by thin section electron
microscopy (Figure 2). As expected, a significant bacterial
replication was observed in the cytosol of infected cells 24 h
post-infection with wild-type LVS. Of 363 cells counted, 33 were
infected by bacteria (9.1%) and 64% of the infected cells contained
more than 10 bacteria. Bacterial multiplication had also occurred
at 24 h in cells infected with the ggt mutant. However, only 5% of
the cells were infected by bacteria (34/651 cells) and only 20% of
the infected cells contained more than 10 bacteria. These data
strongly suggest that the intracellular growth defect of the ggt
mutant is due to an impaired cytosolic growth.
The impact of ggt inactivation on bacterial virulence was then
evaluated by infecting 6–8 weeks old BALB/c mice with the ggt
mutant and LVS, by the intraperitoneal route (Figure 3 and Table
S1). The median lethal dose was determined to be ,10
1.04 for
LVS and ,10
4.8 for ggt using the Probit method [31], that is a
.1,000-fold attenuation of virulence.
Functional characterization of the ggt mutant
We confirmed that the intracellular growth defect observed in
the ggt mutant strain was due to the specific inactivation of
FTL_0766 by performing a functional complementation of the
gene. For this, the recombinant plasmid pKK-ggt, carrying the
wild-type ggt allele was introduced into the ggt mutant strain. As
shown in Figure 1A, 1B, and 1C, the kinetics of intracellular
multiplication of the complemented strain, monitored in J774,
RAW, bone marrow macrophages, and THP1 cells over a 48 h
period, was indistinguishable from that of wild-type LVS
harboring the plasmid without insert. In mice, complementation
was also observed but appeared to be only partial, possibly to due
in vivo instability of the complementing plasmid (Figure 3).
GGT activity was determined by measuring cleavage and
transfer of a c-glutamyl moiety, with a standard assay used to
monitor blood GGT (performed at the Hospital Necker facility).
We monitored c-glutamyl transpeptidase activity in whole cell
lysates of LVS and of the ggt mutant strain. Inactivation of ggt gene
resulted in very low GGT activity (1.960.6 U/l) whereas the
Author Summary
The role of nutrient acquisition systems in survival and
multiplication of intracellular bacterial pathogens within
infected cells is yet poorly understood. The data presented
here suggest that Francisella tularensis, a highly infectious
facultative intracellular bacterium, is capable of utilizing
glutathione (GSH) and c–glutamyl-cysteine peptides pre-
sent in the cytosol of infected host cells. An in vitro negative
selection method, based on the use of a bacteriostatic
antibiotic, to recover intracellular growth mutants directly
froma pool of mutants, allowed usto selectonemutantina
gene encoding a c-glutamyl transpeptidase (GGT). The
mutant strain showed impaired intracellular multiplication
and was strongly attenuated for virulence in mice. The
cleavage of these cysteine-containing peptides by GGT
activity provides thus the essential source of cysteine
required for intracellular multiplication. The capacity F.
tularensis has evolved to utilize GSH, the most abundant
sourceofcysteineinthehostcytosol, constitutesa modelof
bacterial adaptation to intracellular lifestyle.
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shows that FTL_0766 encodes a c-glutamyl transpeptidase and
that no other protein with c-glutamyl transpeptidase activity exists
in F. tularensis LVS. No GGT activity was detected in culture
supernatants of LVS and mutant strains, indicating that, under the
conditions we tested, the enzyme is not secreted in F. tularensis.
The existence of a capsule-like structure surrounding F. tularensis
has been evoked in several early descriptive papers [32] but its
nature was never characterized neither biochemically nor
genetically. Interestingly, a study which evaluated the serum
resistance of designated ‘‘Capsule-positive’’ and ‘‘Capsule-nega-
tive’’ mutants of F. tularensis, concluded that LPS is the major part
of the capsule and that serum resistance of the Capsule-positive
strains is due to the presence of O-side chains of LPS [33].
Moreover, a series of recent studies [14,16,34] demonstrated a
direct link between LPS O-antigen biogenesis and serum-
resistance. In further support of this notion, a very recent paper
studied complement-mediated lysis and complement C3 deposi-
tion on the F. tularensis surface using a series of LVS strains with
altered in surface carbohydrate structures, including previously
designated Cap- mutants. This study showed that F. tularensis
resistance to complement-mediated lysis was essentially mediated
by the O Ag [35].
Presence of homologs of the genes capB and capC, required for
capsule biosynthesis in Bacillus anthracis, in the genome of F.
tularensis SCHU S4 [27] have led to the hypothesis that F. tularensis
might contain a poly-D-glutamic acid (PGA) capsule. Notably, F.
tularensis mutants in capB, and capC homologs have been recently
isolated in two in vivo screening approaches [19,20]. While these
two studies demonstrated the role of these genes in bacterial
pathogenesis, they did not provide any information on the actual
function of these genes. In B. anthracis, capD allows the covalent
linkage of PGA to the multilayered peptidoglycan and prevents
antibodies from gaining access to the bacterium [36]. We have
recently reported that F. tularensis does not produce poly-D-
glutamate in broth [16]. However, since GGT of LVS shares 35%
similarity with B. anthracis CapD, we examined the impact of ggt
inactivation on sensitivity to non-decomplemented human serum,
using a mutant of LVS devoid of LPS O-antigen and highly
sensitive to serum killing (wbtA) as a control [16]. The serum had
no effect on the viability of the ggt mutant and the wild-type strain
at all tested concentrations (0–20%), while wbtA mutant was
efficiently killed at serum concentrations higher than 2% (Figure 4
and Text S1). Hence, we can say that ggt is not involved in F.
tularensis serum-resistance.
Utilization of extracellular gluthathione and c–glutamyl-
cysteine as cysteine sources
We next examined if the activity of GGT provides a mean for
Francisella to utilize c-glutamyl peptides as a source of amino acids
and specifically cysteine, which is an essential nutrient for
Francisella [37]. For this, LVS, ggt mutant, and the ggt mutant
complemented with the plasmid-encoded ggt gene were cultivated
in defined minimal medium (Chamberlain medium, CDM+) [26]
or in CDM lacking cysteine (CDM-). The medium devoid of
cysteine was supplemented with cysteine, c-glutamyl-cysteine (c-
Glu-Cys), or GSH at 100 mM final concentrations. Cultures were
incubated at 37uC and growth was monitored over a 12 h-period
(Figure 5A). The three strains grew normally in CDM+ medium
while no growth was observed in CDM devoid of cysteine
(CDM2), confirming the absolute cysteine requirement for
growth. Notably, in the absence of cysteine, the addition of
glutathione (GSH) or of c-Glu-Cys partially restored growth of
LVS (Figure 5A), indicating that wild-type LVS is able to use these
exogenous compounds as a source of cysteine. In contrast, the ggt
mutant failed to use these compounds (Figure 5A), confirming that
the GGT activity encoded by FTL_0766 is the only enzyme
capable of hydrolyzing the c-glutamyl-cysteine bond of these
Figure 1. Intracellular replication of LVS, ggt, and ggt-complemented strains. Replication of LVS, ggt, and ggt-complemented strains, inside
J774 murine macrophage-like cells (A); RAW macrophages (B); mouse bone marrow-derived macrophages (BMM) from BALB/c mice (C); and THP1
human macrophages (D). Results are shown as the average log10 CFU/well6standard deviation. Strains are denoted as follows: LVS-pKK214 (X), ggt -
pKK214 (%), and ggt-pKK-ggt (&).
doi:10.1371/journal.ppat.1000284.g001
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able to utilize the c-glutamyl-substates as the LVS strain. The c-
Glu-Cys dipeptide promoted a slightly better growth of LVS than
GSH. This observation is compatible with the fact that with GSH
as a substrate, the action of an additional peptidase is required to
provide cysteine (to cleave the cysteinyl-glycine bond of the
dipeptide released after the digestion with GGT).
Notably, E. coli, which can utilize exogenous glutathione as a
cysteine source in a GGT-dependent manner [38], possesses three
cysteineglycinases (the aminopeptidases PepA, B and N), respon-
sible for the subsequent cleavage of the dipeptide cysteinylglycine
[39]. We identified the three orthologs of these aminopeptidases in
the LVS genome (FTL_1479, FTL_1956, and FTL_1108, sharing
48%, 48% and 38% amino acid identity with PepA, B and N,
respectively). It is thus reasonable to assume that LVS has the
capacity to efficiently cleave cysteinylglycine peptides to produce
cysteine and glycine.
Functional complementation of E. coli ggt by F. tularensis
ggt
To evaluate the capacity of F. tularensis GGT to functionally
complement an E. coli GGT-deficient strain, the LVS ggt gene
(carried on plasmid pKK-ggt) was introduced into E. coli
auxotrophic strains SH795 (thr leu) and SH794 (thr leu ggt) [38]
(kindly provided by Dr. H. Suzuki, Kyoto Institute of Technology,
Figure 2. Intracellular electron microscopy. Transmission electron
micrographs of thin sections of RAW macrophages infected by LVS or
ggt, at T0 and after 24 h infection. At T0, F. tularensis initially resides in a
spacious vacuole at the periphery of the cell (A): LVS. The arrows point
to regions where the phagosomal membrane surrounding the bacteria
is visible. At 24 h, F. tularensis LVS (B) or ggt (C) localized in the
cytoplasm are surrounded by an electron-lucent space. (B,C) Illustrate
cytosolic multiplication of LVS and the ggt mutant, respectively. The bar
to the bottom left corresponds to 0.2 mm (A) or 1 mm (B,C).
doi:10.1371/journal.ppat.1000284.g002
Figure 3. GGT is important for virulence in mice. Survival of BALB/c mice after i.p. infection with LVS, ggt,o rggt-complemented (ggt_C)
bacteria. Groups of five mice were infected with the number of bacteria (log10) shown next to the curves and followed for 9 days.
doi:10.1371/journal.ppat.1000284.g003
Figure 4. Killing of LVS and mutants by non-immune human
serum. Bacteria were incubated with increasing concentrations of
serum, and samples were collected after one hour incubation at 37uC.
The number of viable bacteria was determined by plating onto
chocolate agar plates.
doi:10.1371/journal.ppat.1000284.g004
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plasmid were picked from LB plates and streaked onto M9
minimal agar plates supplemented with threonine and either
leucine (M9+Thr+Leu) or c-glutamyl-leucine (M9+Thr+c-Glu-
Leu). As shown in Figure 6, SH794(pKK-ggt), but not
SH794(pKK214) could grow on (M9+Thr+Leu) as well as on
(M9+Thr+c-Glu-Leu). This assay strongly suggests that F. tularensis
GGT was able to cleave the c-Glu-Leu bond and, thus, to provide
leucine to supplement the leucine auxothrophy of the strain.
Cysteine is required for intracellular multiplication of the
ggt mutant
As the ggt mutant is unable to utilize c-glutamyl substrates in
vitro, we reasoned that the inability of the mutant to replicate inside
macrophages results from this deficiency. We speculated that
cellular GSH (or other c-glutamyl peptides) that cannot be used by
the ggt mutant strain, serve as a source of intracellular cysteine for
F. tularensis. To test this hypothesis, we cultivated J774 macro-
phages in DMEM supplemented with 5 mM cysteine and infected
them with LVS or the ggt strain (non-supplemented DMEM does
not contain cysteine but cystine at a 0.22 mM concentration).
Addition of cysteine to the cell culture medium promotes increased
intracellular growth of the LVS strain compared to growth in J774
cells cultivated in traditional medium (Figure 5B), indicating that
cysteine is limiting in the host cytoplasm. When the ggt strain was
used for infection, bacteria did not multiply in cells cultivated in
normal medium (as seen previously, Figure 1A) but multiplied
intracellularly in J774 cells cultivated in cysteine-enriched medium
(Figure 5B, left panel). In contrast, infection of J774 cells cultivated
in the presence of c-glutamyl-cysteine did not promote growth in
the mutant strain (Figure 5B, right panel). The results show that
the growth defect of the ggt mutant can be circumvented by
addition of cysteine to the medium, strongly suggesting that the
natural intracellular source(s) of cysteine is a c-glutamyl-cysteine
dipeptide and the abundant tripeptide GSH.
The fact that glutathione is involved in many cellular processes,
including oxidative stress defense [40], prompted us to monitor
bacterial growth in the presence or absence of 1 mM H2O2.
Growth of LVS and of the ggt mutant were unaffected by the
presence of 1 mM H2O2 (see Figure S3), indicating that this
concentrationofH2O2isnon-toxictoLVSandthattheggtmutation
does not increase H2O2 sensitivity. Of note, this value is still 100-
fold above the physiological concentration of H2O2 that bacteria
encounter in phagocytes during the oxidative burst generated by
NADPH oxidase, which is in the 1–10 mM range [41,42,43,44].
Thus, it reasonable to assume that that the phenotype of the mutant
not related to increased susceptibility to oxidative stress.
GGT-dependent incorporation of cysteine from GSH into
proteins
To further demonstrate that cysteine from GSH was indeed
incorporated into proteins, we then performed a metabolic
Figure 5. Cysteine is required for F. tularensis growth. (A) Growth of LVS and the ggt mutant in chemically defined medium (CMD)
supplemented with various sources of cysteine. The OD600 of the cultures were monitored during 12 h of growth at 37uC with agitation in complete
CDM (CDM+) or in CDM lacking cysteine (CDM2) and supplemented with either c-Glu-Cys or GSH. (B) Replication of LVS and ggt mutant inside J774
cells in the presence or absence of cysteine 5 mM (left panel); or in the presence or absence of c-Glu-cys 1 mM (right panel).
doi:10.1371/journal.ppat.1000284.g005
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and ggt mutant bacteria were grown in Chamberlain medium
devoid of cysteine (CMD2) and supplemented with either
100 mM GSH (LVS+GSH, ggt+GSH) or 100 mM cysteine
(LVS+cys, Dggt+cys).
35S Radiolabeled-GSH (Perkin Elmers)
was added to each culture and the suspensions were incubated
for 8 h at 37uC with agitation (in the radiolabled c-Glu-Cys-Gly
molecule, the isotope is on the sulfur of the central cysteine residue
CH2SH side chain). Bacteria collected by centrifugation were
resuspended in SDS-PAGE loading buffer, boiled and loaded onto
10%-SDS-polyacrylamide gels. After electrophoresis, gels were
vacuum-dried and scanned with a Molecular Dynamics Phos-
phorimager. The autogradiograph shown in Figure 7A corre-
sponds to 12 h exposure. As a control, a second gel loaded with
the same extracts was Coomassie-blue-stained (Figure 7B). As
expected, in CMD2 supplemented with GSH, only residual
growth was observed with the ggt mutant. In contrast, growth of
LVS and the ggt mutant were identical in CMD2 supplemented
with cysteine. Radiolabeld protein bands were detected (Figure 7A)
only in the two LVS protein extracts (+GSH or +Cys). This assay
demonstrates that GSH utilization specifically requires the action
of the ggt gene product and that cysteine from GSH is directly
incorporated into proteins during bacterial growth.
Discussion
The role of nutrient acquisition systems in survival and
multiplication of intracellular bacterial pathogens within infected
cells is poorly understood. Using a cefotaxime-based negative
selection, we identified a gene, encoding a c-glutamyl transpep-
tidase (GGT, FTL_0766) that is absolutely required for intracel-
lular multiplication and virulence of F. tularensis LVS. The data
presented here suggest that F. tularensis is capable of utilizing
glutathione (GSH) and c-glutamyl-cysteine peptides present in the
cytosol of infected host cells. The cleavage of these cysteine-
containing peptides by GGT activity thus provides the essential
source of cysteine required for intracellular multiplication.
Critical role of GGT in Francisella pathogenesis
Screenings of banks of mutants have been previously reported in
F. tularensis [7,18,19,20,21,45]. A number of genes were repeatedly
found by these different approaches, in particular genes involved
in purine/pyrimidine synthesis. Notably, three of these studies
identified the ggt gene [19,21,45] but its properties were not further
characterized.
GGT shares some sequence similarity with the CapD enzyme
responsible for covalent anchoring of the B. anthracis capsule. The
existence of a capsule surrounding F. tularensis has been evoked
repeatedly but never persuasively demonstrated experimentally.
Therefore, we evaluated the impact of ggt inactivation on serum
resistance of LVS as the putative Francisella capsule confers serum
resistance [46]. The ggt mutant showed a serum resistance
comparable to that of wild-type LVS, demonstrating that GGT
is not involved in serum resistance.
Inactivation of ggt had a drastic effect on the ability of LVS to
multiply in eukaryotic cells. Strikingly, we showed that the
intracellular growth defect of the ggt mutant could be eliminated
by providing external cysteine to the culture medium, establishing
a direct link between GGT activity and cysteine availability. Also,
the capacity of the ggt mutant to cause disease in mice was severely
decreased, further demonstrating the critical role of GGT in
pathogenesis.
Figure 6. Functional complementation of E. coli ggt with ggt of F. tularensis. E. coli auxotrophic strains SH794 (thr leu ggt) and SH795 (thr leu)
containing pKK214 or pKK-ggt (encoding F. tularensis GGT), grown on M9 minimal agar plates supplemented with threonine and either leucine (Leu),
c-glytamyl-leucine (cGluLeu), or no leucine source (none).
doi:10.1371/journal.ppat.1000284.g006
GGT in F. tularensis Pathogens
PLoS Pathogens | www.plospathogens.org 6 January 2009 | Volume 5 | Issue 1 | e1000284GGT allows utilization of c-glutamyl peptides as a source
of cysteine
The involvement of GGT in the utilization of glutathione or
other c-L-glutamyl peptides has been demonstrated in both
prokaryotes and eukaryotes [38,47,48,49,50]. While some bacte-
rial species have the capacity to directly import GSH from the
growth medium and degrade it into glutamate and cysteine in
their cytoplasm [51], species such as H. pylori cannot transport this
substrate and must secrete or export GGT to degrade GSH
extracellularly. GGT of H. pylori has been described as a virulence
factor essential for the establishment of the infection in the mouse
model [52,53,54] and as an apoptosis-inducing protein [55].
Furthermore, a role for GGT in the metabolism of glutamine and
glutathione has been recently established, providing information
on the role of the enzyme in the physiopathology of this
extracellular bacterial pathogen [56]. We did not detect any
GGT activity in culture supernatants of LVS under the conditions
we tested, suggesting that GGT-mediated degradation of c-
glutamyl compounds occurs in the bacterial cytoplasm. Future
work will be required to address the molecular mechanisms of
uptake of these compounds in F. tularensis.
Our results show that both GSH and c-glutamyl-cysteine can
functionally replace cysteine to support growth of Francisella in
broth, and that GGT activity is required for this, by cleaving the c-
glutamyl-cysteine linkage. We also showed that F. tularensis GGT
could functionally complement an E. coli GGT-deficient strain.
The F. tularensis GGT was able to cleave the c-Glu bond of the
dipeptide c-Glu-Leu, allowing, like the genuine E. coli enzyme, the
utilization of the dipeptide as a source of amino acid (providing
leucine to supplement the leucine auxothrophy of the strain).
Finally, a metabolic labeling assay confirmed that GSH
utilization, as a source of cysteine, specifically requires the action
of the ggt gene product. Furthermore, the use of radiolabeled-
GSH, carrying the
35S isotope on the cysteine side chain,
demonstrated that cysteine from GSH is indeed incorporated into
bacterial proteins during growth.
A model of GSH utilization by intracellular F. tularensis
The infectious cycle of F. tularensis is essentially intracellular.
Since the severe intracellular growth defect of the ggt mutant could
be completely relieved by the addition of free cysteine to the cell
culture medium, it seems most likely that GGT provides a source
of cysteine to cytosolic bacteria by degrading internalized c-
glutamyl-cysteine peptides.
GSH is the most abundant non-protein thiol in mammalian
cells and the prevalent low-molecular weight peptide in eukaryotic
cells, attaining concentrations of 1 to 10 mM in many different cell
types, most of which (85–90%) is present in the cytosol.
Biosynthesis of GSH is dependent on the availability of the amino
acid precursors glutamate, glycine, and cysteine. The intracellular
pool of cysteine is relatively small (0.10–0.25 mM) and cysteine is
generally the limiting amino acid for GSH synthesis (the other two
precursors, glycine and glutamate, are found in considerable
higher intracellular concentration). It is estimated that at the low
levels of c-glutamyl-cysteine normally present, 95% is converted to
GSH (see for reviews [23,57,58] and references therein).
Figure 7. Metabolic labeling. LVS and ggt mutant bacteria were grown in CDM devoid of cysteine, supplemented with either GSH (lanes LVS+GSH,
ggt+GSH) or cysteine (lanes LVS+Cys, ggt+Cys). Radiolabeled
35S-GSH was added to each culture and the suspensions were incubated for 8 h at 37uC
with agitation. Bacterial pellets were resuspended in SDS-PAGE loading buffer, and 5 ml of each fraction were loaded onto 10%-SDS-polyacrilamide
gels. Each well corresponds to ca. 1.8610
8 bacteria for LVS+GSH, LVS+Cys, and ggt+Cys; and to 0.6610
8 bacteria for ggt+GSH. After electrophoresis,
gels were vacuum-dried and scanned with a Molecular Dynamics Phosphorimager. The autogradiograph shown in (A) corresponds to 12 h exposure.
As control, a second gel loaded with the same fractions was Coomassie-blue-stained (B).
doi:10.1371/journal.ppat.1000284.g007
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tularensis (Figure 8), in which intracellular F. tularensis uses c-
glutamyl-cysteine dipeptide and GSH as the primary sources of
cysteine. The ggt mutant, unable to cleave the c-glutamyl-cysteine
bond, does not obtain sufficient free cysteine (or cystine) from its
surroundings to support growth. Therefore, only the addition of
mM amounts of free cysteine compensates its enzymatic
deficiency. Utilization of cytosolic GSH and/or cysteine-contain-
ing dipeptides as a source of cysteine might be used by other
intracellular bacterial pathogens.
More generally, acquisition of nutrients should be considered as
an integral part of the pathogenicity of intracellular bacteria. This
concept is comforted by recent transcriptomic analyses, which
revealed the upregulation of many bacterial metabolic and
transport functions in infected cells (see for examples
[59,60,61,62]). A remarkable example of the interplay between
intracellular pathogens and their host has been provided with L.
monocytogenes. Indeed, it has been shown that a listerial membrane
transporter, Hpt, was essential for acquisition of phosphorylated
hexoses within the cystosol of infected cells and was, thus, of major
importance for bacterial replication [63,64]. Clearly, intracellular
bacterial pathogens have adapted a fine balance between their
metabolic needs and the nutrients available (nature and concen-
tration), to multiply efficiently and to avoid a premature death of
the host cell that would lead to an aborted infection.
Materials and Methods
Strains, media, and chemicals
F. tularensis LVS strain was obtained from Dr Anders Sjo ¨stedt
(Umea ˚ University, Sweden), and grown at 37uC in Schaedler K3
(Biomerieux SA Marcy l’Etoile, France) broth, Chamberlain
defined synthetic medium [26] or Chocolate agar enriched with
PolyViteX (chocolate agar) (Biomerieux SA Marcy l’Etoile,
France). E. coli was grown in Luria-Bertani (LB) medium at
37uC. When required, medium was supplemented with kanamycin
(10 mgm l
21). Kanamycin was purchased from Sigma-Aldrich (St
Louis, MO). Oligonucleotide primers were synthesized by
Eurogenetec. Primers and bacterial strains used in this study are
listed in Table S2.
Generation of banks of LVS mutants and in vitro
screening procedure
Banks of transposon insertion mutants were generated in LVS,
by using the in vivo Himar strategy (HimarFT) [30]. The thermo-
sensitive plasmid pFNLTP16 H3 used (kindly provided by Dr.
Dara W. Frank, Medical College of Wisconsin), carries, between
the inverted repeats, the npt gene (determining kanamycin
resistance) under the control of the F. tularensis LVS groEL
promoter. Classically, 10 ml of Schaedler K3 medium was
inoculated with LVS transformed with Himar 3, and grown
overnight at 30uC with shaking to the until late exponential phase
(optical density at 600 nm, 0.7–0.9). Cultures were then grown
twice overnight at 39uC and once at 40uC in the presence of
kanamycin, to eliminate non-integrated plasmid in these bacteria.
Cultures were finally stored in 1.5 ml fractions at 280uC.
The murine macrophage-like cells J774 were infected with pools
of ca. 10
7 mutant bacteria (at an MOI of 100 bacteria/cell). After
1 h infection, cells were washed three times with fresh culture
medium and incubated for 24 h in DMEM supplemented with 5%
(v/v) fetal calf serum, 10 mgm 1
21 gentamycin (to kill extra-
cellular bacteria) and 1.5 mg ml
21 cefotaxime (to kill growing
intra-cellular bacteria). At given time-points, cells were washed
and lysed with 1 ml of sterile water and plated on chocolate agar
enriched with PolyViteX. Plates were incubated at 37uC for 3 days
and clones obtained were isolated and stocked. Classically, after
24 h of infection, each selection (i.e. one 12-wells plate seeded with
10
5 cells per well) led to the subsequent isolation of approximately
20 colonies on chocolate agar plates containing kanamycin.
Screening procedure. Ninety-five clones were isolated after
cefotaxime selection and were tested by Southern blot. In 65
clones, multiple bands were detected (from 2 to 5), indicating that
several transposition events had occurred (most likely due to non-
even loss of the plasmid after passages at non-permissive
temperature, as confirmed by a recent study) [21]. These clones
were not further studied.
Single insertions were observed in 30 clones (Figure S2).
Nucleotide sequence analysis of these 30 single transposon
insertions led to the identification of 10 distinct chromosomal
regions (Table S1). One double insertion mutant was also
analyzed. The genes identified are involved in various processes
including metabolism and cell division. Notably, in many instances
(Table S1), the same insertion was isolated several times (up to 10
times), possibly due to a bias in the selection procedure after
repeated passages at non-permissive temperature and/or during
intracellular survival in the presence of cefotaxime.
Figure 8. A model of utilization of GSH and c-Glu-Cys by
cytosolic F. tularensis. F. tularensis requires cysteine for growth. It can
utilize GSH (and its oxidized form GSSG), c-Glu-Cys, cysteine, and
cystine as sources of cysteine. In eukaryotic host cells, the intracellular
concentration of GSH depends on the availability and transport of
cystine (oxidized form of cysteine) and cysteine. Cytosolic GSH, the
most abundant thiol-containing compound (present in the mM range),
and c-Glu-Cys serve as sources of cysteine for intracellular growth of F.
tularensis. In wild-type bacteria, GSH and c-Glu-Cys are processed by
GGT to produce c-Glu and Cys-Gly or c-Glu and Cys, respectively. The
Cys-Gly dipeptide is further processed by other amino-acid peptidases
to produce free cysteine and glycine. GGT-negative bacteria are unable
to process these compounds, and the available concentration of free
cysteine is too low to promote bacterial growth.
doi:10.1371/journal.ppat.1000284.g008
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Macrophage infections were performed as described previously
[65] (see Text S1). For determination of numbers of intracellular
bacteria, cells were washed three times with fresh culture medium
and lysed with 1 ml of sterile water, serially diluted, and plated on
chocolate agar.
Functional complementation
The plasmid used for complementation of the ggt mutant, pKK-
ggt, was constructed by amplifying a 2,206 bp fragment
(corresponding to the sequence 300 bp upstream of the ggt gene
to 100 bp downstream the gene) using primers D1 and D2 (see
Table S2), followed by digestion with XbaI and cloning into the
XbaI site of plasmid pKK214 [66]. The plasmids pKK214 and
pKK-ggt were introduced into LVS and the ggt mutant by
electroporation.
Functional complementation of E. coli ggt by F. tularensis
ggt
We used the same E. coli - F. tularensis shuttle plasmids to
evaluate the capacity of F. tularensis GGT to functionally
complement an E. coli GGT-deficient strain. The plasmids
pKK214 and pKK-ggt were introduced into E. coli auxotrophic
strains SH795 (thr leu) and SH794 (thr leu ggt) [38] (kindly provided
by Dr. H. Suzuki, Kyoto Institute of Technology, Japan). Colonies
of the E. coli strains containing the recombinant plasmid were
picked from LB plates and streaked onto M9 minimal agar plates
supplemented with thiamine (2 mg/ml), threonine (100 mg/ml),
and when indicated either leucine (100 mg/ml) or c-glutamyl-
leucine (100 mg/ml), and incubated for 72 hours at 37uC.
Metabolic labeling
LVS and ggt mutant bacteria were collected from Chocolate
agar plates and resuspended in Chamberlain medium devoid of
cysteine to a final OD600 of 0.11. Each 10 ml culture was
supplemented with either GSH at 100 mM final (LVS+GSH,
ggt+GSH) or cysteine at 100 mM final (LVS+cys, ggt+cys).
Radiolabeled glutathione (
35S-GSH, Perkin Elmer) was then
added to each culture (10 mCi of
35S-GSH at a specific activity
of 30 Ci/mmol per 10 ml culture) and the suspensions were
incubated for 8 h at 37uC with agitation. Bacteria were finally
collected by centrifugation and the pellets were resuspended in
SDS-PAGE loading buffer. Five 5 ml of each fraction (correspond-
ing to 0.15 ml of bacterial culture) were loaded onto 10%-SDS-
polyacrilamide gels.
The culture of LVS+GSH and the two cultures in the presence
of cysteine (LVS+Cys, ggt+Cys) grew to a final OD of 0.6, while
that of ggt+GSH reached only an OD600 of 0.2. Thus, for
LVS+GSH, LVS+Cys and ggt+Cys, each well corresponds to ca.
1.8610
8 bacteria; while for Dggt+GSH, it corresponds only to
0.6610
8 bacteria.
After electrophoresis, gels were vacuum-dried and scanned with
a Molecular Dynamics Phosphorimager. The autogradiograph
shown corresponds to 12 h exposure.
As control, a second gel loaded with the same fractions was
Coomassie-blue-stained.
Gammaglutamyl transpeptidase enzyme assays
Ten ml overnight culture of wild type and the ggt mutant were
centrifuged and pellets were suspended in 1 ml of Schaedler K3.
0.5 ml of Zorkonium bead was added and mixture was agitated in
3 series of 30 sec at speed of 40 in FastPrep apparatus (GMI, Inc.,
Minnesota, USA). Samples were centrifuged (3,5006g, 5 min) and
supernatants collected (whole cell lysates). GGT activity assay was
realized on 50 ml of each sample (corresponding to 10
9 bacteria),
using a standard dosage procedure (Hospital Necker-Enfants
Malades, on a Roche/Hitachi analyzer). Values are indicated in
U/l, as calculated by the analyser. Four independent measure-
ments were performed.
Animal studies
Groups of five 6–8 week old female BALB/c mice (Janvier, Le
Genest St Isle, France), were i.p. injected with 0.2 ml of Francisella
in 0.15 M NaCl. The number of viable bacteria used for infection
was determined by plating serial dilutions on chocolate agar. The
survival of mice was followed for 10 days. Animal experiments
were performed according to the INSERM guidelines for
laboratory animals husbandry.
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